Pirtobrutinib, a highly selective, non-covalent (reversible) BTK inhibitor in relapsed/refractory follicular lymphoma: Results from the phase 1/2 BRUIN study Meeting Abstract
| Authors: | Shah, N. N.; Zinzani, P. L.; Wang, M. L.; Nasta, S. D.; Lech-Maranda, E.; Ogawa, Y.; Fakhri, B.; Kuss, B.; Miyashita, K.; Patel, K.; Coombs, C. C.; Ma, S.; Patel, M.; Barve, M. A.; Tessoulin, B.; Stathis, A.; Kim, W. S.; Ennishi, D.; Hashimoto, D.; Kojima, K.; Zelenetz, A. D.; Cohen, J. B.; Vose, J. M.; Maddocks, K. J.; Munir, T.; Sun, F. F.; Bian, F.; Tsai, D. E.; Abada, P.; Cheah, C. Y. |
| Abstract Title: | Pirtobrutinib, a highly selective, non-covalent (reversible) BTK inhibitor in relapsed/refractory follicular lymphoma: Results from the phase 1/2 BRUIN study |
| Meeting Title: | 65th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 142 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2023 Dec 9-12 |
| Meeting Location: | San Deigo, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2023-11-02 |
| Start Page: | 3026 |
| Language: | English |
| ACCESSION: | WOS:001159740302135 |
| DOI: | 10.1182/blood-2023-181309 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract -- Source: Wos |
